Literature DB >> 5456807

4-alkyl-5-aryl-4H-1,2,4-triazole-3-thiols as hypoglycemic agents.

M Y Mhasalkar, M H Shah, S T Nikam, K G Anantanarayanan, C V Deliwala.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5456807     DOI： 10.1021/jm00298a021

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  6 in total

1.  The in vivo metabolism of 5-(4-nitrophenyl)-4-(2-phenylethyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione in rats.

Authors:  E E Oruç; L Kabasakal; S Rollas
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2003 Apr-Jun       Impact factor: 2.441

2.  N-(2-Chloro-phen-yl)-2-({5-[4-(methyl-sulfan-yl)benz-yl]-4-phenyl-4H-1,2,4-triazol-3-yl}sulfan-yl)acetamide.

Authors:  Hoong-Kun Fun; Chin Sing Yeap; K Manjunath; D Jagadeesh Prasad; Boja Poojary
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-07-16

3.  Synthesis and antimicrobial activity of some novel fused heterocyclic 1,2,4-triazolo [3,4-b][1,3,4] thiadiazine derivatives.

Authors:  Jagdish K Sahu; Swastika Ganguly; Atul Kaushik
Journal:  J Adv Pharm Technol Res       Date:  2014-04

4.  Synthesis, molecular docking, and biological evaluation of Schiff base hybrids of 1,2,4-triazole-pyridine as dihydrofolate reductase inhibitors.

Authors:  D Dewangan; Y Vaishnav; A Mishra; A K Jha; S Verma; H Badwaik
Journal:  Curr Res Pharmacol Drug Discov       Date:  2021-04-15

5.  Synthesis of Schiff and Mannich bases of new s-triazole derivatives and their potential applications for removal of heavy metals from aqueous solution and as antimicrobial agents.

Authors:  Zeinab A Hozien; Ahmed F M El-Mahdy; Ahmad Abo Markeb; Laila S A Ali; Hassan A H El-Sherief
Journal:  RSC Adv       Date:  2020-05-27       Impact factor: 4.036

6.  Synthesis and Antibacterial Evaluation of New Thione Substituted 1,2,4-Triazole Schiff Bases as Novel Antimicrobial Agents.

Authors:  Karim Akbari Dilmaghani; Fazel Nasuhi Pur; Mahnaz Hatami Nezhad
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.